Thomas W. Ross Sr., Director at Valeant Pharmaceuticals International, Inc. (VRX), bought 4,000 shares at $24.40 ($98K) on 2016-06-13, disclosed to the SEC on 2016-06-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VRX | BUY | 2016-12-16 | $74K | — | Filing → |